Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: Frequent involvement of hepatitis B virus

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 1920-1928

  Yotsuyanagi, Hiroshi ^a,b   Shintani, Yoshizumi ^a   Moriya, Kyoji ^a   Fujie, Hajime ^a   Tsutsumi, Takeya ^a   Kato, Tomohiro ^b   Nishioka, Kusuki ^b   Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^a   Iino, Shiro ^b   Kimura, Satoshi ^a   Koike, Kazuhiko ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TORQUE TENO VIRUS; VIROLOGY;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DNA VIRUSES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

EID: 0034047747     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315512     Document Type: Article

References (36)

1. 1. Kiyosawa K, Sodeyama T, Tanaka E, et al., Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
2. 2. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995;15:64-9.
3. 3. Brechot C, Jaffredo F, Lagorce D, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998;29:173-83.
4. 4. Annual report of the Ministry of Health and Welfare of Japan, 1998. Tokyo: Ministry of Health and Welfare, 1998;231-2 [Japanese].
5. 5. Brechot C, Degos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen. N Engl J Med 1985;312:270-6.
6. 6. Lai MY, Chen PJ, Yang PM, Shen JC, Sung JL, Chen DS. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990;12:575-81.
7. 7. Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323: 80-5.
8. 8. Coursaget P, Le Cann P, Leboulleux D, Diop MT, Bao O, Coll AM. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett 1991;67:35-8.
9. 9. Sheu JC, Huang GT, Shih LN, et al. Hepatitis C and B viruses in hepatitis B surface antigen negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-7.
10. 10. Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B virus and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-9.
11. 11. Liang TJ, Jeffers LJ, Reddy KR, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993;18:1326-33.
12. 12. Yoshizawa H, Watanabe J. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan. Curr Stud Hematol Blood Transfus 1994;61:182-94.
13. 13. Yotsuyanagi H, Moriya K, Shintani Y, et al. Hepatitis G virus in the liver and serum of patients with hepatocellular carcinoma. Hepatol Res 1997;8: 21-7.
14. 14. Kubo S, Nishiguchi S, Kuroki T, et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997;27:91-5.
15. 15. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
16. 16. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 1998;12:233-9.
17. 17. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19: 1513-20.
18. 18. Yotsuyanagi H, Koike K, Yasuda K, et al. Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995;76:1352-5.
19. 19. Fujiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res 1983;11:4601-10.
20. 20. Yotsuyanagi H, Yasuda K, Iino S, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998;27:1377-82.
21. 21. Okamoto H, Takahashi M, Nishizawa T, et al. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 1999;259:428-36.
22. 22. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998;54:249-55.
23. 23. Kratz PA, Bottcher B, Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 1999;96:1915-20.
24. 24. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-10.
25. 25. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 1983;11:1747-57.
26. 26. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22-6.
27. 27. Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997;26:1658-66.
28. 28. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993;17:538-44.
29. 29. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-8.
30. 30. Penna A, Artini M, Cavalli A, et al., Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996;98:1185-94.
31. 31. Yotsuyanagi H, Koike K, Yasuda K, et al. Intrahepatic levels of hepatitis C virus RNA after interferon treatment: eradication of the minus strand RNA correlates sustained remission of hepatitis. Int Hepatol Commun 1995;3:82-90.
32. 32. Tagger A, Donalo F, Ribero ML, et al. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma: the Brescia HCC study. Hepatology 1999;301:294-9.
33. 33. Nagaya T, Nakamura T, Tokino T, et al. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1987;1:773-82.
34. 34. Yaginuma K, Kobayashi M, Yoshida E, Koike K. Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci USA 1985;82:4458-62.
35. 35. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 1995;38:134-42.
36. 36. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21: 313-21.